Conclusion: In people with type 2 diabetes, the cardiovascular and kidney benefits of GLP-1 receptor agonists are consistent regardless of SGLT2 inhibitor use.
PubMed 39210781 ↗Hcg
The short answer. More people than not who report on Hcg say it helped (64% of 53). It is most often used for hormones: 85% of 41 reports say that improved. It is well studied — 324 meta-analyses on PubMed. The most common complaint is suppression.
From 190 mentions in total — the rest didn't say how it went and aren't counted.
What Hcg does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 324 meta-analyses on PubMed ↗ · 972 randomized trials ↗
Conclusion: These findings suggested that CoQ10 pretreatment is an effective intervention in improving IVF/ICSI outcomes for women with DOR. Still, this meta-analysis included relatively limited sample sizes with poor descriptions of their methodologies. Rigorously conducted trials are needed in the future.
PubMed 39129455 ↗Conclusion: This systematic review provides convincing evidence of the efficacy of gonadotropins for pubertal induction. However, there remains substantial heterogeneity in treatment choice, dose, duration, and outcomes assessed. Formal guidelines and randomized studies are needed.
PubMed 38128110 ↗Conclusion: We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.
PubMed 39608381 ↗922 human trials on ClinicalTrials.gov test Hcg — 514 completed, 71 recruiting now. See all on ClinicalTrials.gov ↗
- Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females · Polycystic Ovary Syndrome, Infertility, Female · 2025
- Abatacept Conversion in Kidney Transplantation · Renal Transplant Recipient · 2026
- One-shot Ovarian Stimulation Protocol (One-shot) · Infertility, Female · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 40 research projects with Hcg in the title, $20,549,094 in total (1985–2023). NIH RePORTER ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“hcg.. although it may raise estrogen too much. worked great for me, strength increases, amazing libido, lost some fat.”
“When I stopped TRT and went to HCG mono therapy 1500iu EOD kept my total test at 1500.”
“I used to take HCG... I stopped and feel much better (less e2)”
“I got euphoria once from HCG once (after this it stopped working).”
Hcg compared
Other options for hormones
Sources
- User reports: 190 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate